🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A migraine is a moderate to severe headache typically on one side of the he...
Status
Active Not Recruiting
Location
Central Research Associates /ID# 260161
Start Date
2024-09-10
Trial ID
NCT06417775
Treatments Being Tested
Migraine is a common neurological disorder typically characterized by attac...
Status
Recruiting
Location
Rehabilitation & Neurological Services /ID# 229969
Start Date
2022-01-13
Trial ID
NCT05125302
Treatments Being Tested
The purpose of this study is to characterize the pharmacokinetics of MK-160...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01657370
Treatments Being Tested
This study will evaluate the long-term safety and tolerability of intermitt...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2016-09-13
Trial ID
NCT02873221
Treatments Being Tested
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant...
Status
Completed
Location
Achieve Clinical Research, LLC /ID# 237098
Start Date
2020-08-21
Trial ID
NCT04492020
Treatments Being Tested
This study will evaluate the efficacy, safety, and tolerability of 2 doses ...
Status
Completed
Location
Clinical Research Advantage, Inc./Simon Williamson Clinic
Start Date
2016-08-26
Trial ID
NCT02867709
Treatments Being Tested
This study will evaluate the efficacy, safety, and tolerability of 2 doses ...
Status
Completed
Location
Clinical Research Advantage, Inc./Desert Clinical Research, LLC.
Start Date
2016-07-22
Trial ID
NCT02828020
Treatments Being Tested
The purpose of this study is to assess the effectiveness, safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2012-07-01
Trial ID
NCT01613248
Treatments Being Tested
The main goal of this trial is to learn more about the safety and tolerabil...
Status
Completed
Location
Clinical Neuroscience Solutions
Start Date
2024-09-13
Trial ID
NCT06578585
Treatments Being Tested